Kidney Transplant Inflammation and Graft Loss
Kidney transplant inflammation may affect how well a transplanted kidney functions over time. A 2023 cohort study found that transplant recipients with higher levels of systemic inflammation early after surgery were more likely to experience long-term graft loss. The study does not prove that inflammation alone causes a transplant to fail, but it suggests that the body’s inflammatory environment may be an important factor in long-term transplant health.
Protecting a kidney transplant involves more than watching a single creatinine or estimated glomerular filtration rate result. Medication adherence, regular laboratory testing, blood pressure management, healthy food choices, infection prevention and close communication with the transplant team all play essential roles.
Kidney transplant inflammation cannot always be felt or recognized through symptoms. Routine appointments and blood tests may reveal signs of rejection, medication problems or declining kidney function before a recipient notices physical changes.
Kidney Transplant Inflammation: What It Means
Inflammation is part of the immune system’s natural response to surgery, infection, tissue injury and other forms of physical stress. Some inflammation is expected after kidney transplantation because the recipient has undergone major surgery and the immune system naturally recognizes the donated kidney as foreign tissue.
This immune reaction is why transplant recipients must take anti-rejection medications. Without these medicines, the immune system may attack the donated kidney and damage its ability to function.
Researchers are particularly interested in persistent, low-grade systemic inflammation. This type of inflammation may not cause obvious pain, redness or fever. Instead, it may be reflected through patterns of inflammatory substances circulating in the blood.
Kidney transplant inflammation is not one specific disease or laboratory result. Inflammatory markers can rise because of infection, immune activation, tissue injury, smoking, metabolic problems, reduced kidney function or other health complications.
A single inflammation marker cannot determine whether a transplanted kidney is failing. Results must be evaluated alongside creatinine, eGFR, urine protein, blood pressure, anti-rejection medication levels, imaging and, when necessary, a kidney biopsy.
What the 2023 Study Found
The study, published in Frontiers in Immunology in October 2023, included 699 adult kidney transplant recipients treated at Oslo University Hospital between 2009 and 2012.
Researchers measured 21 inflammatory and related biomarkers approximately 10 weeks after transplantation. They combined the findings into one overall inflammation score and five pathway-specific scores.
Participants were followed for a median of 9.1 years. During the study period, 84 recipients experienced death-censored graft loss, meaning their transplanted kidney failed while they were still alive.
Recipients in the highest quarter of the overall inflammation score had approximately three times the risk of graft loss compared with recipients in the lowest quarter. Vascular inflammation and fibrogenesis, a process involved in creating scar tissue, stood out in the analysis.
The researchers also compared the blood-based inflammation scores with kidney biopsy findings. The vascular inflammation score was associated with inflammatory changes found in biopsies performed six weeks and one year after transplantation.
The fibrogenesis score was associated with interstitial fibrosis and tubular atrophy. These are forms of scarring and structural damage that may interfere with the kidney’s long-term function.
Why the Findings Matter
The study provides valuable information, but its findings must be interpreted carefully. It was an observational study, which means it identified an association between inflammation and graft loss but did not prove that inflammation directly caused the transplanted kidneys to fail.
It also does not prove that lowering one inflammation marker with a particular food, supplement or medication would prevent graft loss.
The researchers used a specialized combination of 21 biomarkers. This inflammation score is not a standard laboratory test routinely ordered for all kidney transplant recipients.
The findings may eventually help researchers and transplant specialists identify recipients at greater risk of graft injury. They may also support the development of better tools for detecting vascular inflammation and fibrosis before significant kidney damage occurs.
Long-term graft loss is usually multifactorial. This means that several problems may contribute at the same time. Possible contributors can include:
- Acute or chronic rejection
- Infections
- Medication toxicity
- Uncontrolled blood pressure
- Diabetes
- Smoking
- Recurrent kidney disease
- Donor-specific antibodies
- Reduced kidney function
- Missed anti-rejection medication
The study’s authors noted that rejection, calcineurin-inhibitor toxicity, infections and recurrence of the original kidney disease are among the important causes of long-term graft loss.
Food and Lifestyle Support
A nutritious eating pattern may support blood pressure, cardiovascular health, weight management and overall recovery after transplantation. However, diet cannot replace anti-rejection medication, laboratory testing or transplant follow-up.
Kidney recipients generally have more food choices after transplantation than they did while receiving dialysis. However, the appropriate diet may change in response to medication side effects, laboratory results, blood pressure, weight and kidney function.
The NIDDK recommends working with a dietitian to develop an individualized post-transplant eating plan.
When laboratory results and medical restrictions allow, meals may include:
- Fresh vegetables
- Fruits
- Whole grains
- Beans and legumes
- Fish
- Poultry
- Eggs
- Plant-based protein sources
- Healthy unsaturated fats
Highly processed foods, fast food, fried food, sugary beverages, processed meats and foods containing excessive amounts of sodium should be limited.
A lower-sodium diet may be especially helpful for recipients experiencing high blood pressure, swelling or fluid retention. Excessive sodium can contribute to fluid buildup and make blood pressure more difficult to control.
A plant-forward eating pattern may be appropriate for many transplant recipients, but it is not automatically suitable for everyone. Potassium, phosphorus, blood sugar, digestive tolerance and kidney function must be considered.
Hydration should also be individualized. Drinking water throughout the day may be appropriate, but forcing excessive amounts of fluid is not a proven method for eliminating kidney transplant inflammation. It could also be unsafe for someone with impaired kidney function, heart problems, swelling or a prescribed fluid restriction.
Follow the fluid amount recommended by your transplant nephrologist or transplant center.
Other supportive lifestyle habits include getting adequate sleep, participating in approved physical activity, maintaining a healthy weight, managing stress and avoiding tobacco.
These habits cannot guarantee that a transplant will last indefinitely, but they may reduce avoidable stress on the kidney and support overall cardiovascular and metabolic health.
Medication Adherence and Safety
Taking every anti-rejection medication exactly as prescribed is one of the most important steps a transplant recipient can take.
These medicines help prevent the immune system from recognizing the donated kidney as foreign and attacking it. Doses should never be skipped, doubled, reduced or stopped without instructions from the transplant team.
Regular monitoring is equally important. Some anti-rejection medications can affect blood pressure, blood sugar, the liver or the transplanted kidney itself.
Transplant teams use blood tests to measure medication levels and monitor kidney and liver function. These results help determine whether medication doses need to be adjusted.
Recipients should tell their transplant team about vomiting, diarrhea, difficulty swallowing medication or problems obtaining prescription refills. Vomiting and diarrhea may interfere with medication absorption and can lead to dehydration.
Do not automatically take an extra medication dose after vomiting. Contact the transplant team for individualized instructions.
Prescription medications, over-the-counter products and pain relievers should also be reviewed with the transplant team. Some medicines may affect kidney function or interact with anti-rejection medication.
Supplement Precautions After Transplant
Supplements marketed for inflammation require special caution after kidney transplantation.
Herbal products, concentrated plant extracts, vitamins, minerals and combination supplements may interact with anti-rejection medications. They may alter how medications are absorbed, processed or removed from the body.
Possible concerns include changes in:
- Tacrolimus or cyclosporine levels
- Blood pressure
- Potassium levels
- Blood sugar
- Bleeding risk
- Liver function
- Immune system activity
- Medication absorption
Products described as natural are not automatically safe for a kidney transplant recipient.
Before using vitamin E, curcumin, CoQ10, herbal tea, medicinal mushrooms or any other supplement, provide the transplant pharmacist or nephrologist with the exact product label, ingredient list, serving size and planned frequency.
The transplant team can evaluate whether the product could interfere with tacrolimus, cyclosporine, sirolimus, mycophenolate, prednisone or other prescribed medicines.
Supplements should never be used as replacements for anti-rejection medication or as do-it-yourself treatments for suspected rejection or kidney transplant inflammation.
Monitoring and Warning Signs
Rejection may begin before a transplant recipient feels any physical changes. Routine blood testing can reveal early warning signs and allow the transplant team to adjust medication before the problem becomes more serious.
Do not miss recommended:
- Blood tests
- Urine tests
- Medication-level testing
- Blood pressure checks
- Transplant appointments
- Imaging or biopsy appointments
Contact the transplant center promptly when experiencing symptoms such as:
- Fever
- Reduced urine output
- New swelling
- Sudden weight gain
- Pain near the transplanted kidney
- Burning during urination
- Drainage from the surgical scar
- A persistent cough or illness
- Vomiting or diarrhea
- Difficulty taking anti-rejection medication
- Unusual fatigue or weakness
Anti-rejection medicines weaken the immune system and can make infections more difficult to recognize. The NIDDK advises recipients to contact their transplant center when they feel unwell or develop possible signs of infection, including fever, surgical-site drainage, burning during urination or a persistent cough.
Do not wait for the next routine appointment when infection, rejection, dehydration or medication toxicity may be developing. Early evaluation gives the transplant team the best opportunity to identify and treat a potentially reversible problem.
Kidney Transplant Inflammation: The Bottom Line
The 2023 study provides meaningful evidence that higher systemic inflammation early after kidney transplantation is associated with long-term graft loss and inflammatory or fibrotic changes found in kidney biopsies.
However, the research does not establish a do-it-yourself treatment or prove that one food, supplement or laboratory marker determines how long a transplant will function.
The safest response to kidney transplant inflammation is to focus on proven transplant-care fundamentals:
- Take medications exactly as prescribed.
- Complete all recommended laboratory testing.
- Control blood pressure and blood sugar.
- Avoid smoking.
- Follow an individualized eating plan.
- Stay physically active as approved.
- Report possible infections promptly.
- Discuss every supplement with the transplant team.
These steps cannot eliminate every risk, but they provide a transplanted kidney with the strongest practical support possible.
